Sort
50,496 grants matching “lung cancer”
Targeting Lymph Node Dependent Immune Tolerance in Cancer
$527,382Edgar G. Engleman · Stanford University · R01 · FY2023 · CA
Novel Radiomics for Predicting Response to Immunotherapy for Lung Cancer
$527,355Anant Madabhushi · Emory University · R01 · FY2025 · CA
Investigating Max as a tumor suppressor gene in small cell lung cancer and other neuroendocrine tumors
$527,348Robert Neil Eisenman · Fred Hutchinson Cancer Center · R01 · FY2024 · CA
COSMOS Eye: Cataract and AMD in a Trial of a Multivitamin and Cocoa Extract
$527,205William G Christen · Brigham And Women'S Hospital · R01 · FY2016 · EY
Epigenetic Mechanisms of Gene Expression in Thoracic Malignancies
$527,174David Schrump · Division Of Basic Sciences - Nci · ZIA · FY2020 · CA
Project 1: Health Effects of Arsenic Longitudinal Study
$527,167Joseph H Graziano · Columbia University Health Sciences · P42 · FY2014 · ES
Structural and functional principles of activation and regulation of the transient receptor potential channel TRPV3.
$527,117Alexander Sobolevsky · Columbia University Health Sciences · R01 · FY2025 · AR
New Chemical Methods for Molecular Imaging to Impact Clinical Care
$527,049Tobias Ritter · Harvard University · R01 · FY2012 · EB
Metabolic regulation of KLHL proteins through O-glycosylation
$526,958Jen-Tsan Ashley Chi · Duke University · R01 · FY2020 · NS
Metabolic regulation of KLHL proteins through O-glycosylation
$526,958Jen-Tsan Ashley Chi · Duke University · R01 · FY2021 · NS
Metabolic regulation of KLHL proteins through O-glycosylation
$526,958Jen-Tsan Ashley Chi · Duke University · R01 · FY2022 · NS
Truncated O-glycan-dependent mechanisms inducing metastatic dissemination in pancreatic cancer
$526,941Moorthy P. Ponnusamy · University Of Nebraska Medical Center · R01 · FY2022 · CA
Multi Source E-Beam kV X-Ray Tube for Image-Guided Radiotheraphy
$526,918Douglas P Boyd · Telesecurity Sciences, Inc. · R44 · FY2017 · CA
Targeting SMARCA2 as a therapeutic strategy in SMARCA4 mutant lung cancer
$526,882Yonathan Lissanu · University Of Tx Md Anderson Can Ctr · R01 · FY2023 · CA
Targeting bidirectional signaling in lung stroma and cancer cells
$526,874Uwe Rix · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2018 · CA
TARGETING DEUBIQUITINASE USP10 TO POTENTIATE IMMUNOTHERAPY IN LUNG CANCER
$526,738Wayne State University · · FY2022 · Defense Health Agency
Proton-coupled folate/antifolate transport
$526,718Israel David Goldman · Albert Einstein College Of Medicine · R01 · FY2009 · CA
Project 1: Health Effects of Arsenic Longitudinal Study
$526,713Joseph H Graziano · Columbia University Health Sciences · P42 · FY2012 · ES
Proteostasis Reprogramming in Mutant KRAS-Driven Cancers
$526,651Xi Chen · University Of Tx Md Anderson Can Ctr · R01 · FY2025 · CA
Clinical Protocols in the Cancer Signaling Networks Section
$526,625Udayan Guha · Division Of Basic Sciences - Nci · ZIA · FY2018 · CA
Targeting ATM to boost systemic effects of radiotherapy and immunotherapy
$526,563Chuan-Yuan Li · Duke University · R01 · FY2021 · CA
Targeting ATM to boost systemic effects of radiotherapy and immunotherapy
$526,563Yunyan Jennifer Jennifer Zhang · Duke University · R01 · FY2025 · CA
Identifying and Targeting Mechanisms for Membrane Signaling in Human Cancer
$526,562Eric Alejandro Sweet-Cordero · University Of California, San Francisco · R01 · FY2024 · CA
Understanding intrinsic resistance to direct KRAS inhibition in colorectal cancers
$526,540John D Gordan · University Of California, San Francisco · R37 · FY2025 · CA
INVESTIGATING FIELD CANCERIZATION IN NON-SMALL CELL LUNG CANCER SUBTYPE USING EMERGING GENOMIC APPROACHES
$526,498Rutgers, The State University Of New Jersey · · FY2022 · Defense Health Agency